Results 31 to 40 of about 1,868,246 (184)

Antibiotic Associated Diarrhea in Hospitalized Adult Patients

open access: yesThe Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy, 2018
Background: Antibiotic associated diarrhea (AAD) occurs from the first initiation until 2 months of the end of antibiotic treatment. The aims of this study were to know the incidence of AAD, Clostridium difficile infection and other gastrointestinal ...
Marcellus Simadibrata   +3 more
doaj   +1 more source

Extraintestinal Clostridioides difficile infection

open access: yesIDCases, 2020
Clostridioides (Clostridium) difficile is the major cause of healthcare antibiotic-associated diarrhoea. However, extra-intestinal manifestations of Clostridioides (Clostridium) difficile infection (CDI) (including bacteremia and tissue infection) are ...
Zhao Hai   +6 more
doaj   +1 more source

Clostridium difficile Infection in Children [PDF]

open access: yesJAMA Pediatrics, 2013
Clostridium difficile is the most common cause of health care-associated diarrhea among adults in the United States and is associated with significant morbidity and mortality. During the past decade, the epidemiology of C difficile infection (CDI) has changed, including a rise in the rate and severity of infection related to the emergence of a ...
Julia Shaklee, Sammons   +2 more
openaire   +2 more sources

Calprotectin and lactoferrin faecal levels in patients with Clostridium difficile infection (CDI): a prospective cohort study. [PDF]

open access: yes, 2014
Measurement of both calprotectin and lactoferrin in faeces has successfully been used to discriminate between functional and inflammatory bowel conditions, but evidence is limited for Clostridium difficile infection (CDI).
Beadsworth, Mike B.J.   +42 more
core   +1 more source

Clostridium difficile cure with fecal microbiota transplantation in a child with Pompe disease: a case report

open access: yesJournal of Medical Case Reports, 2018
Background Recurrent Clostridium difficile infection is a growing problem among children due to both the increasing survival of medically fragile children with complicated chronic medical conditions resulting in prolonged antibiotic exposure and ...
D. E. Dow, P. C. Seed
doaj   +1 more source

Clostridium Difficile and COVID-19: Novel Risk Factors for Acute Portal Vein Thrombosis

open access: yesCase Reports in Vascular Medicine, 2021
The COVID-19 pandemic has created an unprecedented global health care crisis. COVID-19 patients are found to have increased thrombotic risk. Despite being on prophylactic anticoagulation, many develop serious arterial and venous thromboembolic events ...
Venkata Ram Pradeep Rokkam   +5 more
doaj   +1 more source

The analysis of para-cresol production and tolerance in Clostridium difficile 027 and 012 strains. [PDF]

open access: yes, 2011
BACKGROUND: Clostridium difficile is the major cause of antibiotic associated diarrhoea and in recent years its increased prevalence has been linked to the emergence of hypervirulent clones such as the PCR-ribotype 027. Characteristically, C.
McNerney Ruth   +23 more
core   +1 more source

Recurrent Pseudomembranous Colitis in an Ovarian Cancer Patient Undergoing Carboplatin Chemotherapy

open access: yesCase Reports in Obstetrics and Gynecology, 2016
Background. Diarrhea is a common problem in ovarian cancer patients undergoing chemotherapy and Clostridium difficile infection has been identified as a cause.
Valerie A. Allen   +2 more
doaj   +1 more source

Clostridium difficile – still a problem among the XXI century in case of geriatic patient

open access: yesJournal of Medical Science, 2017
Introduction. The disease caused by Clostridium difficile (CzcD - Clostridium difficile -associated disease) - was defined by the Centres for Disease Control and Prevention in Atlanta in 2007 in order to standardize monitoring conditions of diarrhea ...
Agnieszka Ulatowska   +7 more
doaj   +1 more source

Cost-effectiveness analysis of fidaxomicin versus vancomycin in Clostridium difficile infection [PDF]

open access: yes, 2014
OBJECTIVES: Fidaxomicin was non-inferior to vancomycin with respect to clinical cure rates in the treatment of Clostridium difficile infections (CDIs) in two Phase III trials, but was associated with significantly fewer recurrences than vancomycin.
Cornely, Oliver A.   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy